Usefulness of Low Dose Oral Contrast Media in ![]() |
An Young-Sil
(Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine)
Yoon Joon-Kee (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Hong Seon Pyo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Joh Chul-Woo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) Yoon Seok-Nam (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of medicine) |
1 | Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-79 |
2 | Dizendorf EV, Treyer V, Von Schulthess GK, Hany TF. Application of oral contrast media in coregistered positron emission tomography-CT. AJR 2002;179:477-81 DOI ScienceOn |
3 | Garrett PR, Meshkov SL, Perlmutter GS. Oral contrast agents in CT of the abdomen. Radiology 1984;153:545-6 DOI |
4 | Otsuka H, Graham MM, Kubo A, Nishitani H. The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 2005; 19(2): I 01-8 DOI |
5 | Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. Cause and magnitude of the error induced by oral CT contrast agent in CT -based attenuation correction of PET emission studies. J Nucl Med 2003;44:732-8 |
6 | Antoch G, Kuehl H, Kanja J, Lauenstein TC, Schneemann H, Hauth E, et al. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 2004;230:879-85 DOI ScienceOn |
7 | Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS et al. Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging. 1999 Oct;2( 5):273-9 DOI ScienceOn |
8 | Cohade C, Osman M, Nakamoto Y, Marshall LT, Links JM, Fishman EK et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003;44:412-6 |
9 | Tsang BD, Panacek EA, Brant WE, Wisner DH. Effect of oral contrast administration for abdominal computed tomography in the evaluation of acute blunt trauma. Ann Emerg Med 1997;30:7-13 DOI ScienceOn |
10 | Warshauer DM, Wehmueller MD, Molina PL, Muller KE, DeLuca MC, Lee JK. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagons and oral CT contrast materials. Radiology 1997;202:394-8 DOI |
11 | Jadvar H, Schambaye RB, Segall GM. Effect of atropine and sincalide on the intestinal uptake of F -18 fluorodeoxyglucose. Clin Nucl Med 1999;24:965-7 DOI |
12 |
Geral A, Lutz SF, Thomas B, et al. To enhance or not to enhance? |
13 | Stafford RE, McGonigal MD, Weigelt JA, Johnson TJ. Oral contrast solution and computed tomography for blunt abdominal trauma: a randomized study. Arch Surg 1999;134:622-6 DOI ScienceOn |
14 | Mitchell DG, Bjorgvinsson E, terMeulen D, Lane P, Greberman M, Friedman AC. Gastrografin versus dilute barium for colonic CT examination: a blind, randomized study. J Comput Assist Tomogr 1985;9:451-3 DOI ScienceOn |
15 | Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. Effect of oral contrast agents on CT -based PET attenuation correction in dual-modality PET/CT image. Invest Rad. 2003; 38:784-9 |
16 | Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants, Eur J Nucl Med Mol Imaging. 2002; 29:367-70 DOI ScienceOn |
17 | Hausegger K, Reinprecht P, Kau T, Igerc I, Lind P. Clinical experience with a commercially available negative oral contrast medium in PET/CT. Rofo 2005;177:796-9 DOI ScienceOn |
18 | Groves AM, Kayani I, Dickson JC, Townsend C, Croasdale I, Syed R et al. Oral contrast medium in PET/CT: should you or shouldn't you? Eur J Nucl Med Mol Imaging 2005;4(epub). DOI:10.1007/s00259-005-1833-9 |
![]() |